Vacsera
VACSERA emphasized that vaccinations are not limited to childhood, as many believe, but are also crucial for the elderly and adults of all ages.
The Ministry of Health and Population announced that the seasonal influenza vaccine will soon be available through the Holding Company for Biological Products and Vaccines (VACSERA), ahead of the winter season and the start of the school year.
The Holding Company for Biological Products and Vaccines (VACSERA) has launched a new awareness campaign to emphasize the importance of receiving the pneumococcal vaccine.
The Holding Company for Biological Products and Vaccines (VACSERA) has addressed the ongoing debate regarding the impact of vaccinations on the immune system, confirming that vaccines do not weaken immunity. Instead, they strengthen the immune system and prepare it to fight diseases more effectively.
Egypt’s state-owned vaccine producer VACSERA has said that the seasonal influenza vaccine is available throughout the year, stressing that immunity begins to develop about two weeks after vaccination, helping reduce both the risk of infection and the severity of complications.
The Holding Company for Serums and Vaccines (Vacsera) said that cervical cancer is the sixth most common type of cancer affecting women.
The Minister’s comments were stated during a meeting with the Egyptian holding company for biological products and vaccines (Vacsera).
Dr. Mostafa Mohammadi, Director of the National Vaccination Center in Vaxera, confirmed in statements that the syncytial virus is rapidly spreading among children, adding, "It will never reach the level of a pandemic and it has existed for many years."
According to a statement by the Ministry of Health, the complex, which belongs to Egypt’s Holding Company for Biological Products and Vaccines (VACSERA), was constructed in cooperation with the Chinese biopharmaceutical company Sinovac over 3,180 square meters.
Abdel Ghaffar’s remarks were made during the opening of a vaccine cooling and storage complex of the country’s Holding Company for Biological Products and Vaccines (VACSERA) in the Sixth of October city in Giza.
Influenza vaccine is effective in preventing infection with the disease from 50 to 60%, he continued.
The Vacsera factory complex, located in October city, is scheduled to produce 400 million doses of veterinary vaccines for bird flu, in addition to 7 other vaccines related to animal production.
Under the deal, the two countries would cooperate to establish a fully-automatic vaccine-storing complex at VACSERA factories in Giza's 6th of October City.
Egypt’s government denied, Monday the rumors that there was a shortage of drugs in the treatment protocols for the Coronavirus and oxygen stocks in the isolation hospitals, coinciding with the fourth wave of the virus.
Egypt will receive two million Sinovac doses from China within days, Health Ministry Spokesman Khaled Megahed told Egypt Today.
Health Minister Hala Zayed said Egypt seeks to allocate a production line in its Egyptian Holding Company for Biological Products and Vaccines (VACSERA) for the manufacturing of the vaccine of the American pharmaceutical company Moderna.
Egypt’s Prime minster Mostafa Madbouli said, Monday that the government noticed that Egyptians started to abandon COVID-19 precautionary measures.
President of the Holding Company for Biological Products and Vaccines "Vacsera" Dr. Heba Wali, revealed the details of the Egyptian Medicines Authority's approval of the Vacsera-Sinovac vaccine, adding that by the end of this year, the largest vaccine factory will be inaugurated.
Egypt’s Health Minister Hala Zayed announced on Wednesday the reception of the first million doses of the Sinovac vaccine manufactured locally after finishing evaluation tests.
The Egyptian Drug Authority (EDA) has permitted VACSERA -Sinovac vaccine the emergency use license as the first locally-manufactured vaccine against Coronavirus.
